1. Home
  2. FTH vs LCLN Comparison

FTH vs LCLN Comparison

Compare FTH & LCLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Faeth Therapeutics Inc. Common Stock

FTH

Faeth Therapeutics Inc. Common Stock

N/A

Current Price

$24.48

Market Cap

860.0M

Sector

Health Care

ML Signal

N/A

Logo Lincoln International Inc. Class A Common Stock

LCLN

Lincoln International Inc. Class A Common Stock

N/A

Current Price

$24.34

Market Cap

722.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
FTH
LCLN
Founded
N/A
N/A
Country
United States
Employees
29
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
860.0M
722.5M
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
FTH
LCLN
Price
$24.48
$24.34
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
306.9K
337.2K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.50
$20.05
52 Week High
$37.90
$25.20

Technical Indicators

Market Signals
Indicator
FTH
LCLN
Relative Strength Index (RSI) 41.68 56.97
Support Level $23.82 $21.23
Resistance Level $31.61 $24.40
Average True Range (ATR) 2.65 1.24
MACD -0.69 0.02
Stochastic Oscillator 16.06 80.48

Price Performance

Historical Comparison
FTH
LCLN

About FTH Faeth Therapeutics Inc. Common Stock

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

About LCLN Lincoln International Inc. Class A Common Stock

Lincoln International Inc is an independent investment banking advisory company focused on private capital markets. The company operates its business through its two operating segments: Investment Banking Advisory and Valuations and Opinions. The Investment Banking Advisory segment offers a range of services related to mergers and acquisitions, with key areas of focus including sell-side advisory, buy-side advisory, asset sales and divestitures, restructuring, primary and secondary capital raising, and merger-related engagements. The Valuations and Opinions segment provides valuation services to investment funds and financial institutions. The majority of revenue is derived from the Investment Banking Advisory segment. Geographically, the maximum revenue is derived from the Americas.

Share on Social Networks: